LPA Receptor
LPA receptor belongs to GPCRs and is important for lipid signaling.
Products Related to LPA Receptor(12)
- GC11374Ki16425CAS: 355025-24-0Purity: >98.00%
Ki16425 is an antagonist of the lysophosphatidic acid receptors LPA1 and LPA3 and Ki values are 0.25 and 0.36μM respectly. Ki16425 reduces the LPA-induced activation of p42/p44 MAPK.Blocks LPA-induced dephosphorylation of Yes-associated protein (YAP) and WW domain-containing transcription regulator protein 1 (TAZ), inhibiting the Hippo signaling pathway.
- GC14436H2L5186303CAS: 139262-76-3Purity: >98.00%
H2L5186303 is a selective lysophosphatidic acid receptor 2 (LPA₂; IC₅₀=9nM) antagonist.
- GC151401-Oleoyl lysophosphatidic acid sodium saltCAS: 325465-93-8Purity: >98.00%
1-Oleoyl lysophosphatidic acid (1-Oleoyl-sn-glycero-3-phosphate) sodium, as a potent bioactive phospholipid, is a LPA receptor activator.
- GC17617Tetradecyl PhosphonateCAS: 4671-75-4Purity: >98%
pan-antagonist of lysophosphatidic acid 1 (LPA1), LPA2, and LPA3 receptors
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC11374 | Ki16425 | 355025-24-0 | >98.00% | |
Ki16425 is an antagonist of the lysophosphatidic acid receptors LPA1 and LPA3 and Ki values are 0.25 and 0.36μM respectly. Ki16425 reduces the LPA-induced activation of p42/p44 MAPK.Blocks LPA-induced dephosphorylation of Yes-associated protein (YAP) and WW domain-containing transcription regulator protein 1 (TAZ), inhibiting the Hippo signaling pathway. | ||||
| GC14436 | H2L5186303 | 139262-76-3 | >98.00% | |
H2L5186303 is a selective lysophosphatidic acid receptor 2 (LPA₂; IC₅₀=9nM) antagonist. | ||||
| GC15140 | 1-Oleoyl lysophosphatidic acid sodium salt | 325465-93-8 | >98.00% | |
1-Oleoyl lysophosphatidic acid (1-Oleoyl-sn-glycero-3-phosphate) sodium, as a potent bioactive phospholipid, is a LPA receptor activator. | ||||
| GC15428 | H2L 5765834 | 420841-84-5 | >99.00% | |
lysophosphatidic acid receptors antagonist | ||||
| GC15808 | TC LPA5 4 | 1393814-38-4 | >98% | |
TC LPA5 4 is a potent LPA5-selective receptor antagonist and a heparanase inhibitor with IC 50 values of 0.8μM and 10μM, respectively. | ||||
| GC12362 | ONO-7300243 | 638132-34-0 | >98.00% | |
LPA1 antagonist | ||||
| GC13476 | AM966 | 1228690-19-4 | >98.50% | |
A potent and selective LPA 1 receptor antagonist | ||||
| GC15220 | AM095 | 1345614-59-6 | >99.50% | |
AM095 is a selective, orally bioavailable LPA1 antagonist with an IC 50 value of 0.73μM for mouse LPA1. | ||||
| GC15908 | AM-095 free base | 1228690-36-5 | >99.00% | |
A selective LPA 1 receptor antagonist | ||||
| GC16558 | DBIBB | 1569309-92-7 | >98.00% | |
LPA2 agonist | ||||
| GC17617 | Tetradecyl Phosphonate | 4671-75-4 | >98% | |
pan-antagonist of lysophosphatidic acid 1 (LPA1), LPA2, and LPA3 receptors | ||||
| GC15062 | Ki16198 | 355025-13-7 | >98.50% | |
LPA antagonist | ||||
